AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with the AI alerting medical review teams to identify potential adverse events (AEs), data anomalies, critical issues for patients on treatment, and more.
Related Posts
Undue Burden Created by Protocol Deviations
Jim Wahl, vice president, client services, TruLab In the clinical trial ecosystem these days, patient-centricity has become quite the buzzword.…
First-Line Treatment with Calquence Plus Chemoimmunotherapy Found to Improve Survival in Patients with Mantle Cell Lymphoma
Image credit: David A Litman | stock.adobe.com Calquence (acalabrutinib; AstraZeneca) plus standard-of-care chemoimmunotherapy produced a statistically significant and clinically meaningful improvement…
YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials
Applied Clinical Trials: Could you tell our audience a bit about YPrime? Jim Corrigan: First, thanks so much for having…